Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 6/20 | 0.57 |
| ▸ | CTSS | P25774 | 5/20 | 0.57 |
| ▸ | CTSB | P07858 | 2/20 | 0.57 |
| ▸ | CTSL | P07711 | 1/20 | 0.57 |
| ▸ | REN | P00797 | 3/20 | 0.54 |
| ▸ | AKT1 | P31749 | 1/20 | 0.53 |
| ▸ | ACE | P12821 | 1/20 | 0.53 |
| ▸ | GNPAT | O15228 | 1/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.51 |
| ▸ | NPY4R | P50391 | 1/20 | 0.49 |
| ▸ | PPARG | P37231 | 1/20 | 0.48 |
| ▸ | PPARA | Q07869 | 1/20 | 0.48 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.48 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22117445 | 1.00 | CTSK (0.57) | CTSKCTSSCTSBCTSLREN | |
| SCHEMBL5966551 | 1.00 | CTSK (0.57) | CTSKCTSSCTSBCTSLREN | |
| SCHEMBL22117446 | 1.00 | CTSK (0.57) | CTSKCTSSCTSBCTSLREN | |
| SCHEMBL22117444 | 1.00 | CTSK (0.57) | CTSKCTSSCTSBCTSLREN | |
| SCHEMBL22674864 | 0.97 | CTSS (0.56) | CTSKCTSSCTSBCTSLREN | |
| SCHEMBL30645707 | 0.92 | CTSS (0.58) | CTSKCTSSNPY4RITGB3ITGA2B | |
| SCHEMBL23680477 | 0.92 | CTSK (0.59) | CTSKCTSSCTSBCTSLREN | |
| SCHEMBL23275569 | 0.92 | CTSK (0.59) | CTSKCTSSCTSBCTSLREN | |
| SCHEMBL23275571 | 0.92 | CTSK (0.59) | CTSKCTSSCTSBCTSLREN | |
| SCHEMBL7850315 | 0.91 | CTSK (0.62) | CTSKCTSSCTSBCTSLREN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060128613-A1 | Melanocortin receptor ligands | THE PROCTER & GAMBLE COMPANY | 2006-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060128613-A1 | Melanocortin receptor ligands | MC3R, MC4R, MC1R | CTSK 3132/4885CTSS 2475/4885CTSB 2294/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.